13 May, 2024
- Specialist-initiated androgen deprivation therapy (ADT/hormonal therapy is the mainstay of prostate cancer treatment and is often continued for long periods of time, with prescribing ongoing in primary care
- In Addition to adverse drug effects such as hot flushes, fatigue and sexual issues, hormonal therapy can also affect a patient's cardiometabolic, bone and mental health
- Pharmacological and non-pharmacological treatments can alleviate the burden of adverse effects associated with hormonal therapy, increase adherence and reduce distress for patients
- Prescribers should be aware that there are many potential drug-drug interactions and some important specialist-led monitoring requirements associated with hormonal therapy